Chris Leiske

924 total citations · 1 hit paper
10 papers, 562 citations indexed

About

Chris Leiske is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Chris Leiske has authored 10 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Molecular Biology. Recurrent topics in Chris Leiske's work include Monoclonal and Polyclonal Antibodies Research (7 papers), HER2/EGFR in Cancer Research (5 papers) and Peptidase Inhibition and Analysis (5 papers). Chris Leiske is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), HER2/EGFR in Cancer Research (5 papers) and Peptidase Inhibition and Analysis (5 papers). Chris Leiske collaborates with scholars based in United States. Chris Leiske's co-authors include Robert P. Lyon, Peter D. Senter, Martha E. Anderson, Svetlana O. Doronina, Steven Duniho, Jocelyn R. Setter, Joshua H. Hunter, Fu Li, Cindy Balasubramanian and Tim D. Bovee and has published in prestigious journals such as Angewandte Chemie International Edition, Blood and Nature Biotechnology.

In The Last Decade

Chris Leiske

10 papers receiving 532 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates

2014 358 citations Robert P. Lyon, Jocelyn R. Setter et al. Nature Biotechnology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chris Leiske United States	7	322	322	298	145	56	10	562
Jonathan D. Bargh United Kingdom	9	597 1.9×	549 1.7×	452 1.5×	260 1.8×	73 1.3×	9	1.0k
Heidi L. Perez United States	6	235 0.7×	220 0.7×	211 0.7×	88 0.6×	38 0.7×	9	449
Raffaele Colombo Italy	16	206 0.6×	153 0.5×	321 1.1×	220 1.5×	45 0.8×	33	652
Nicola Ashman United Kingdom	6	273 0.8×	265 0.8×	202 0.7×	130 0.9×	29 0.5×	8	456
Margaret S. Cooper United Kingdom	13	157 0.5×	132 0.4×	197 0.7×	79 0.5×	77 1.4×	23	536
Julia H. Cochran United States	9	207 0.6×	184 0.6×	164 0.6×	50 0.3×	46 0.8×	15	358
Warren Viricel Canada	8	197 0.6×	146 0.5×	190 0.6×	58 0.4×	35 0.6×	10	421
Lia Luus United States	10	239 0.7×	247 0.8×	259 0.9×	206 1.4×	37 0.7×	24	649
Francesca Bryden United Kingdom	13	156 0.5×	218 0.7×	155 0.5×	123 0.8×	137 2.4×	16	481
Remon van Geel Netherlands	8	193 0.6×	289 0.9×	365 1.2×	270 1.9×	20 0.4×	9	579

Countries citing papers authored by Chris Leiske

Since Specialization

Citations

This map shows the geographic impact of Chris Leiske's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Leiske with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Leiske more than expected).

Fields of papers citing papers by Chris Leiske

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Leiske. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Leiske. The network helps show where Chris Leiske may publish in the future.

Co-authorship network of co-authors of Chris Leiske

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Leiske. A scholar is included among the top collaborators of Chris Leiske based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Leiske. Chris Leiske is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Moquist, Philip N., Xinqun Zhang, Chris Leiske, et al.. (2024). Reversible Chemical Modification of Antibody Effector Function Mitigates Unwanted Systemic Immune Activation. Bioconjugate Chemistry. 35(6). 855–866. 2 indexed citations

2.

Sandall, Sharsti, Marsha L. Mason, Lori Westendorf, et al.. (2019). Abstract 2688: SGN-CD228A: A novel humanized anti-CD228 antibody-drug conjugate for the treatment of solid tumors. Cancer Research. 79(13_Supplement). 2688–2688. 2 indexed citations

3.

Sandall, Sharsti, Marsha L. Mason, Lori Westendorf, et al.. (2019). Abstract 2688: SGN-CD228A: A novel humanized anti-CD228 antibody-drug conjugate for the treatment of solid tumors. 2688–2688. 1 indexed citations

4.

Sussman, Django, Lori Westendorf, David W. Meyer, et al.. (2018). Engineered cysteine antibodies: an improved antibody-drug conjugate platform with a novel mechanism of drug-linker stability. Protein Engineering Design and Selection. 31(2). 47–54. 47 indexed citations

5.

Kolakowski, Robert V., Kim K. Emmerton, Chris Leiske, et al.. (2016). The Methylene Alkoxy Carbamate Self‐Immolative Unit: Utilization for the Targeted Delivery of Alcohol‐Containing Payloads with Antibody–Drug Conjugates. Angewandte Chemie. 128(28). 8080–8083. 8 indexed citations

6.

Kolakowski, Robert V., Kim K. Emmerton, Chris Leiske, et al.. (2016). The Methylene Alkoxy Carbamate Self‐Immolative Unit: Utilization for the Targeted Delivery of Alcohol‐Containing Payloads with Antibody–Drug Conjugates. Angewandte Chemie International Edition. 55(28). 7948–7951. 56 indexed citations

7.

Gordon, Kristine A., Sharsti Sandall, Marsha L. Quick, et al.. (2016). SGN-CD48A: a Novel Humanized Anti-CD48 Antibody-Drug Conjugate for the Treatment of Multiple Myeloma. Blood. 128(22). 4470–4470. 16 indexed citations

8.

Gordon, Kristine A., Sharsti Sandall, Jamie B. Miyamoto, et al.. (2016). Abstract 1195: SGN-CD352A: A novel humanized anti-CD352 antibody-drug conjugate for the treatment of multiple myeloma. Cancer Research. 76(14_Supplement). 1195–1195. 12 indexed citations

9.

Lyon, Robert P., Jocelyn R. Setter, Tim D. Bovee, et al.. (2014). Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates. Nature Biotechnology. 32(10). 1059–1062. 358 indexed citations breakdown →

10.

Hengel, Shawna, Russell J. Sanderson, John Valliere‐Douglass, et al.. (2014). Measurement of in Vivo Drug Load Distribution of Cysteine-Linked Antibody–Drug Conjugates Using Microscale Liquid Chromatography Mass Spectrometry. Analytical Chemistry. 86(7). 3420–3425. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact